Drug ‘could herald precision medicine’ in multiple myeloma
Results from an international trial of venetoclax may prove to be a watershed, a leading haematological oncologist says.
Results from an international trial of venetoclax may prove to be a watershed, a leading haematological oncologist says.
Professor Mark Dawson is this year's recipient of the Frank Fenner Prize for Life Scientist for his work in developing new epigenetic therapy for t…
The antidepressant discontinued earlier this year has been replaced but will cost patients more.
Results from a small trial show pain relief 20 minutes after application, researchers say.
A head-to-head study pits a second-generation JAK inhibitor against abatacept.
But a large study finds a much lower benefit of monotherapy for patients with Crohn's disease.
After listening to my most recent podcast on toxicology, an anaesthetist friend reflected that his job essentially involves poisoning people with potent toxins. He could…
The American Heart Association has listed drugs of concern and offered new guidance.
Five of 22 products failed to meet standards, the regulator says.
Australian children took part in the trial that could fundamentally change management, authors say.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.